
Just How Steep Is the Drug Patent Cliff? Ask These Pharmas
Big Pharma is staring down the barrel of blockbuster patent expirations over the next few years. Merck’s Keytruda, for example, is far and away the best-selling drug on the planet at the moment, clocking in at nearly $30 billion in worldwide sales in 2024, …